Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Andrew McCulloch
University of California, San Diego, Department: Engineering (All Types)
Should you be removed from our database? Contact us at [email protected]. Read more below.
Insilicomed, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. McCulloch holds (b)(4) equity interest in Insilicomed as a co-founder and a scientific advisor. Insilicomed develops and license state of the art cardiovascular simulation technology. This project is to leverage multi-scale computer simulations growth, fibrosis and remodeling of the heart, validated with animal models, in order to predict consequences of chronic pressure overload on cardiac energetics and metabolism, with long-term goals of discovering novel treatments that can alter the detrimental effects of systemic hypertension on the heart.
Systems Biology of Hypertrophic Heart Disease from Molecular Pathways to Organ System
Narrative Hypertensive heart disease remains a major public health issue and a leading cause of mortality. This research project will leverage novel multi-scale computer simulations growth, fibrosis and remodeling of the heart, validated with animal models, in order to predict consequences of chronic pressure overload on cardiac energetics and metabolism, with long-term goals of discovering novel treatments that can alter the detrimental effects of systemic hypertension on the heart.
Filed on March 27, 2017.
Tell us what you know about Andrew McCulloch's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Andrew McCulloch filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Andrew McCulloch | University of California, San Diego | Conflict of Interest | Insilicomed, Inc. | $60,000 - $79,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.